Publisher Correction: Safety and pharmacodynamics of an engineered E. coli Nissle for the treatment of phenylketonuria: a first-in-human phase 1/2a study.
Puurunen MK, Vockley J, Searle SL, Sacharow SJ, Phillips JA 3rd, Denney WS, Goodlett BD, Wagner DA, Blankstein L, Castillo MJ, Charbonneau MR, Isabella VM, Sethuraman VV, Riese RJ, Kurtz CB, Brennan AM.
Puurunen MK, et al. Among authors: kurtz cb.
Nat Metab. 2022 Sep;4(9):1214. doi: 10.1038/s42255-022-00635-4.
Nat Metab. 2022.
PMID: 35974248
No abstract available.